[ad_1] (AWP / SPU) Geneva-based biopharmaceutical company Obseva will start its second listing at SIX this Friday. The first course costs CHF 15.50, which corresponds to a more than 3% compared to …
Read More »Obseva starts strong on SIX debut | News, analysis and recommendations on brokerage firms | Health of the company
